secwatch.observer — SEC 8-K summary
======================================

Issuer:     4D Molecular Therapeutics, Inc. (FDMT)
CIK:        0001650648
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001193125-23-154338
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

4D Molecular Therapeutics announces shareholder vote results; all director nominees elected and auditor ratified
--------------------------------------------------------------------------------

- At May 23 annual meeting, 27,970,603 of 33,235,726 outstanding shares voted, representing 84.1% quorum.
- Class III directors elected: Nancy Miller-Rich (25,544,878 for, 648,302 withheld), John F. Milligan (26,011,514 for, 181,666 withheld), Shawn Cline Tomasello (20,935,207 for, 5,257,973 withheld).
- Ratification of PricewaterhouseCoopers LLP as auditor for FY2023 passed with 27,957,650 for, 6,435 against, 6,518 abstain.
- Broker non-votes on director election totaled 1,777,423 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650648/000119312523154338/0001193125-23-154338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650648/000119312523154338/d350381d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-154338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer